Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Bosutinib (SKI-606)

InhA, Func 380843-75-4
Catalog No. ABIN3220262

Quick Overview for Bosutinib (SKI-606) (ABIN3220262)

Application

Inhibition Assay (InhA), Functional Studies (Func)
  • Purpose

    Bosutinib is a Bcr-Abl kinase inhibitor for the treatment of Philadelphia chromosome-positive (Ph+) chronic myelogenous leukemia (CML). Compared to other tyrosine kinase inhibitors, it has a more favourable hematologic toxicity profile. FDA approved on September 4, 2012.

    Characteristics

    Tradename: Bosutinib
    Source of Compound: synthetic
    Target: MAPK inhibitor,Src inhibitor,Bcr-Abl inhibitor,CaMK inhibitor,CDK inhibitor
    Receptor: MAPKK2, MAPKKK2,ABL1, Lyn, HCK, Src,Breakpoint cluster region protein(BCR),Bcr-Abl ,CaMK,CDK 2

    Purification

    All the products are sent with COA, HPLC and NMR inspection report to guarantee the quality.

    Purity

    99 %

    Formula

    C26H29Cl2N5O3

    Solubility

    Soluble in DMSO
  • Application Notes

    Optimal working dilution should be determined by the investigator.

    Restrictions

    For Research Use only
  • Format

    Solid

    Storage

    -20 °C

    Storage Comment

    For the majority of compounds, they could be dissolved in DMSO or other organic solvent.
    Their stock solution can be stored at -20°C for up to 3 months and aliquoted for sampling convenience.
    Several freeze/thaw cycles should not damage the activity of our small molecule products.
    However, in many instances the aqueous solutions of some compounds need to be made fresh and cannot be stored. For these compounds, their solution should be prepared just before use and stored no longer than 24 hours.

    Expiry Date

    24 months
  • Background

    Cell cycle/Checkpoint,MAPK Signaling,Neuroscience,Tyrosine Kinase/Adaptors

    Molecular Weight

    530.45 g/mol

    CAS-No

    380843-75-4
You are here:
Chat with us!